- Home
- TPCS vs ANEB Comparison
TPCS vs ANEB Comparison
Compare TPCS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- ANEB
- Stock Information
- Founded
- TPCS 1956
- ANEB 2020
- Country
- TPCS United States
- ANEB United States
- Employees
- TPCS N/A
- ANEB N/A
- Industry
- TPCS Metal Fabrications
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- ANEB Health Care
- Exchange
- TPCS Nasdaq
- ANEB Nasdaq
- Market Cap
- TPCS 42.6M
- ANEB 39.0M
- IPO Year
- TPCS N/A
- ANEB 2021
- Fundamental
- Price
- TPCS $3.74
- ANEB $1.66
- Analyst Decision
- TPCS
- ANEB Strong Buy
- Analyst Count
- TPCS 0
- ANEB 2
- Target Price
- TPCS N/A
- ANEB $5.50
- AVG Volume (30 Days)
- TPCS 29.5K
- ANEB 21.1K
- Earning Date
- TPCS 04-08-2025
- ANEB 05-13-2025
- Dividend Yield
- TPCS N/A
- ANEB N/A
- EPS Growth
- TPCS N/A
- ANEB N/A
- EPS
- TPCS N/A
- ANEB N/A
- Revenue
- TPCS $33,154,058.00
- ANEB N/A
- Revenue This Year
- TPCS N/A
- ANEB N/A
- Revenue Next Year
- TPCS N/A
- ANEB N/A
- P/E Ratio
- TPCS N/A
- ANEB N/A
- Revenue Growth
- TPCS 8.71
- ANEB N/A
- 52 Week Low
- TPCS $2.05
- ANEB $0.80
- 52 Week High
- TPCS $4.42
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- TPCS 54.79
- ANEB 59.78
- Support Level
- TPCS $3.45
- ANEB $1.57
- Resistance Level
- TPCS $3.85
- ANEB $2.00
- Average True Range (ATR)
- TPCS 0.23
- ANEB 0.25
- MACD
- TPCS 0.00
- ANEB 0.00
- Stochastic Oscillator
- TPCS 62.32
- ANEB 30.25
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.